Aller au contenu principal
Retour à l'annuaire
TP
Rhumatologue

Docteur THI PHUONG THAO PHAM

📍 Marseille 9e Arrondissement (13)HospitalierRPPS 10003376778
Publications actives

8 publis sur 5 ans

📊 Reconnaissance scientifique : 3/100📝 11 articles publiés📚 HAL (8)

✨ Profil synthétique

IA · 08/05/2026

Le Docteur THI PHUONG THAO PHAM est un rhumatologue hospitalier à Marseille, avec une production scientifique de 11 publications et un h-index de 3. Ses recherches portent principalement sur des sujets biochimiques et génomiques. Il a également publié des études dans le domaine de la pédiatrie et des essais cliniques.

Expertises présumées

  • Pédiatrie rhumatologique
  • Essais cliniques
  • Revue de littérature médicale
  • Méta-analyse
  • Étude de cas en rhumatologie
  • Recherche en génomique
  • Biochimie appliquée

Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.

Diplômes

🎓 DES & spécialité ordinale

  • DES Rhumatologie
  • Rhumatologie (SM)

🎓 Diplômes

  • DE Docteur en médecine

Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.

Activité de recherche & publications

Source : bases de données publiques (OpenAlex, PubMed).

h-index

3

h articles cités ≥ h fois chacun. Un h de 3 = 3 publications avec 3+ citations.

Citations

149

Publications

11

i10-index

2

Thématiques principales

  • Biochemical and Structural Characterization ×2
  • Genomics and Phylogenetic Studies ×1
  • Phytochemicals and Antioxidant Activities ×1
  • Gut microbiota and health ×1
  • Enzyme Catalysis and Immobilization ×1
Voir sur OpenAlex ↗

Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.

Bibliographie

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Lieu de consultation

  • APHM HOPITAUX SUD SAINTE MARGUERITE

    249 ET 270 — 270 Boulevard DE SAINTE MARGUERITE, 13274 Marseille 9e Arrondissement

    ☎ 0491380000Hospitalier

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

📊 Comprendre le remboursement

Prendre rendez-vous & contact

🗓 Trouver sur Doctolib📇 Ajouter à mes contacts

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

  • 1
    Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study

    Pulmonology · 2025

    📚 14 citations🎯 RCR 6.54🔓 Open Access
  • 2
    EULAR/American College of Rheumatology Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis

    Arthritis & rheumatology (Hoboken, N.J.) · 2026

    📚 8 citations🎯 RCR 8.00
    Lire l'abstract Crossref ↓

    Objective To develop and validate classification criteria for pediatric chronic nonbacterial osteomyelitis (CNO) jointly supported by EULAR and the American College of Rheumatology (ACR). Methods This international initiative had 4 phases: (1) candidate items were proposed in a survey of pediatric rheumatologists, (2) criteria definition and reduction by Delphi and nominal group technique exercises, (3) criteria weighting using multicriteria decision analysis, and (4) refinement of weights and threshold score in a development cohort of 441 patients and validation in another cohort of 514 patients. Results The new EULAR/ACR classification criteria for CNO require typical radiographic or magnetic resonance imaging findings and bone pain as an obligatory entry criterion and exclusion criteria of malignancy, infection, vitamin C deficiency, and hypophosphatasia, followed by additive weighted criteria in 5 clinical (site of bone lesions, pattern of bone lesions, age at onset, coexisting conditions, fever) and 4 pathology/laboratory domains (bone biopsy findings if done, anemia, C‐reactive protein level, and erythrocyte sedimentation rate). A total score ≥55 is required for classification as CNO. The new criteria had a sensitivity of 82% and specificity of 98% in the validation cohort. Conclusion These new classification criteria for pediatric CNO developed with international input reflect current views about CNO, have high specificity and good sensitivity, and provide a key foundation for future CNO research.

  • 3
    Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments

    Allergy · 2026

    📚 6 citations🎯 RCR 6.00🩺 Clinique🔓 Open Access
    Lire l'abstract Crossref ↓

    ABSTRACT Background Allergic rhinitis (AR) impacts quality of life, work and school productivity. Over the last years, an important body of evidence resulting from mHealth data has led to a better understanding of AR. Such advances have motivated an EAACI‐endorsed update of the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines (ARIA 2024–2025). This manuscript presents the ARIA 2024–2025 recommendations for intranasal treatments, one of the mainstays for AR management. Methods The ARIA 2024–2025 guideline panel issued recommendations following the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) evidence‐to‐decision framework. Several sources of evidence were used to inform panel judgments and recommendations, including systematic reviews, evaluation of mHealth and pharmacovigilance data, as well as a survey of experts on costs. Results Eleven guideline questions concerning intranasal treatments for AR were prioritized, leading to recommendations. Overall, these questions concern the choice between different classes of intranasal medications—most notably, intranasal corticosteroids (INCS), antihistamines (INAH), fixed combinations of INAH+INCS and decongestants—or between different individual medications within each class. Four questions had not been evaluated in previous ARIA guidelines, while for the other three there was a change in the strength or directionality of recommendations. Overall, recommendations point to the suggested use of INAH+INCS over INAH or INCS and INCS over INAH. Conclusion This ARIA 2024–2025 article supports patients, their caregivers, and healthcare professionals in choosing an intranasal treatment. However, decisions on AR treatment should consider the clinical variability of the disease, patients' values, and the affordability of medications.

Publications scientifiques (50) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Transversal34

▼

Pédiatrie6

▼

Vraie vie / RWE4

▼

Revue / méta-analyse3

▼

Revue générale3

▼

Case report / série2

▼

Essai clinique2

▼

Microbiote2

▼

Épidémiologie & registres1

▼

Gériatrie1

▼

JAK inhibiteurs1

▼

Datasets & protocoles partagés

Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).

Partager cette fiche

in LinkedIn🟢 WhatsApp✉ Email

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.